BDBM72382 1-(4-methoxy-2,5-dimethyl-phenyl)sulfonyl-2-phenyl-2-imidazoline::1-(4-methoxy-2,5-dimethyl-phenyl)sulfonyl-2-phenyl-4,5-dihydroimidazole::1-(4-methoxy-2,5-dimethylphenyl)sulfonyl-2-phenyl-4,5-dihydroimidazole::1-[(4-methoxy-2,5-dimethylphenyl)sulfonyl]-2-phenyl-4,5-dihydro-1H-imidazole::MLS000690430::SMR000300234::cid_972070

SMILES O=C1c2cc(F)c(Cl)cc2N2CN1c1ccc(=O)[nH]c1NCCCc1c2ccc(F)c1F

InChI Key InChIKey=SPOWNRZYOGHZCT-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72382   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72382BDBM72382(3-Chloro-2,8,9-trifluoro-10,11,12,13-tetrahydro-19...)
Affinity DataIC50: 7.94nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent